18mon MSN
Beezaasan Explotech IPO allotment will be finalised today, February 27. Investors can check their allotment status via Kfin ...
Waaree Energies stock gained 1.60% to Rs 2269.40 against the previous close of Rs 2233.70. The market cap of the firm stood ...
4h
TipRanks on MSNCoreWeave weighs filing $4B IPO within a week, Bloomberg reportsCloud computing company CoreWeave is mulling filing publicly for an IPO in the U.S. within a week, Bloomberg’s Bailey ...
Cloud computing provider CoreWeave is considering filing publicly for an initial public offering in the US within a week, ...
After an improving IPO market in 2024, the IPO market may fare well in 2025, especially with some hot names on deck. That ...
16h
ET Now on MSN1st-ever dividend announced since IPO listing; Feb 28 record dateInternational Gemmological Institute India Ltd (IGIL), a newly-listed company, is set to pay an interim dividend to its ...
NSDL, India's largest depository, is launching a ₹3,000 crore IPO in March, entirely as an offer for sale. Key banking stocks ...
17hon MSN
This will be Boat's second attempt to go public after an abortive attempt in 2022. According to sources, the company is ...
17h
Hosted on MSNAzad Engineering launches Rs 700 crore QIP: All you need to knowThe company's board approved the opening of the issue on February 25 for the QIP of equity shares with a face value of Rs 2 ...
Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...
1d
GOBankingRates on MSNHow To Invest in the ThoughtSpot IPO: A Beginner’s GuideThoughtSpot offers cloud-based solutions to finding and analyzing data in an accurate, rapid, user-friendly manner. Launching ...
Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results